Regencell Bioscience Holdings Limited Ordinary Shares (RGC) Stock Price
RGCStock
$9.59−46.57%52W
Market Cap$4.76B
P/E—
PEG Ratio—
Div yield—
Beta1.82
RGC Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-78.06%
Price vs S&P 500 (4W)63.32%
VGM Score63.77
Industry Peers — Pharmaceutical Preparations(21)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|---|---|---|
RGCRegencell Bioscience Holdings Limited Ordinary Shares | — | — | B | — | — | — | — | $9.59 |
| DFTXDefinium Therapeutics, Inc. Common Shares | — | — | B | — | — | — | — | $32.10 |
| TRLVTrulieve Cannabis Corp. | B | C | A | 1.7x | -3.9% | 59.5% | — | $10.01 |
| CRONCronos Group Inc. Common Share | C | B | A | 6.6x | 37.5% | 46.5% | -50.0% | $3.21 |
| TLRYTilray Brands, Inc. Common Stock | B | B | D | 0.5x | 15.9% | 29.1% | — | $3.04 |
| CGCCanopy Growth Corporation Common Shares | B | C | D | 1.6x | 6.8% | 28.5% | — | $0.71 |
| SNDLSundial Growers Inc. Common Shares | B | C | B | 0.5x | -1.7% | 26.2% | — | $1.25 |
| GLASGlass House Brands Inc. | B | C | D | 1.2x | -25.6% | 30.8% | — | $3.19 |
| USNAUSANA Health Sciences Inc | B | D | C | 0.3x | 5.7% | 77.5% | -37.0% | $15.54 |
| ACBAurora Cannabis Inc. Common Shares | B | D | B | 1.3x | -18.9% | 6.3% | — | $3.99 |
| NAGENiagen Bioscience, Inc. Common Stock | C | C | D | 1.5x | 11.0% | 64.2% | — | $2.49 |
About Regencell Bioscience Holdings Limited Ordinary Shares
Regencell Bioscience Holdings Ltd develops and commercializes traditional Chinese medicine (TCM) treatments for neurocognitive and immune-related disorders. The company's pipeline targets attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and infectious diseases affecting immune function.